8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
Apr 6, 2026·SEC
Material company update
Mar 30, 2026·SEC
Inogen, Inc.(INGN)Earnings, Financials & Key Ratios
INGN•NASDAQ
Price updated Jun 19, 2026
AboutInogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.Show more
- Revenue$349M+3.9%
- EBITDA-$10M+55.6%
- Net Income-$23M+36.6%
- EPS (Diluted)-0.85+44.1%
- Gross Margin47.58%+3.2%
- EBITDA Margin-2.74%+57.3%
- Operating Margin-8.66%+31.6%
- Net Margin-6.52%+39.0%
- ROE-12.43%+34.4%
INGN Key Insights
Inogen, Inc. (INGN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Trading at only 0.9x book value
- ✓Efficient asset utilization: 1.2x turnover
✗Weaknesses
- ✗Profits declining 31.3% over 5 years
- ✗Negative free cash flow
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 14.9% in last year
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when INGN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
INGN Price & Volume
Inogen, Inc. (INGN) stock price & volume — 10-year historical chart
Loading chart...
INGN Growth Metrics
Inogen, Inc. (INGN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years8.17%
5 Years2.48%
3 Years-2.59%
TTM3.39%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM9.41%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM20.87%
Return on Capital
10 Years-4.58%
5 Years-17.62%
3 Years-22.71%
Last Year-13.29%
INGN Recent Earnings
Inogen, Inc. (INGN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.30-25.0%
$0.24
Rev
$85M+3.4%
$82M
Q1 2026
Feb 24, 2026Metric
Actual
Est
EPS
$0.26+27.8%
$0.36
Rev
$82M-3.9%
$85M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.20+9.1%
$0.22
Rev
$92M+4.3%
$89M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.15+31.8%
$0.22
Rev
$92M-1.1%
$93M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.30vs $0.24-25.0% | $85Mvs $82M+3.4% |
| Q1 2026 | Feb 24, 2026 | $0.26vs $0.36+27.8% | $82Mvs $85M-3.9% |
| Q4 2025 | Nov 5, 2025 | $0.20vs $0.22+9.1% | $92Mvs $89M+4.3% |
| Q3 2025 | Aug 7, 2025 | $0.15vs $0.22+31.8% | $92Mvs $93M-1.1% |
Based on last 12 quarters of dataView full earnings history →
INGN Peer Comparison
Inogen, Inc. (INGN) competitors in Respiratory and sleep therapy devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 LNTH | 6.76B | 103.86 | 30.46 | 0.5% | 18.05% | 24.33% | 0.00 | |
 CRVL | 2.97B | 58.53 | 27.35 | 7.03% | 11.51% | 29.92% | 0.05 | |
 APOG | 887.72M | 41.27 | 16.38 | 3.21% | 3.85% | 10.79% | 0.56 | |
 PHM | 24.39B | 126.96 | 11.42 | -3.54% | 12.14% | 15.92% | 0.19 | |
 LUNG | 54.06M | 1.28 | -0.96 | 8.01% | -59.67% | -82.79% | 1.04 | |
 SPXC | 12.19B | 242.97 | 48.02 | 14.17% | 10.8% | 12.37% | 0.22 | |
 LINC | 1.54B | 48.43 | 74.51 | 17.76% | 4.11% | 11.72% | 1.02 | |
 LIN | 237.33B | 512.15 | 35.10 | 2.97% | 20.56% | 17.82% | 0.68 |
Compare INGN vs Peers
Inogen, Inc. (INGN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
INGN Income Statement
Inogen, Inc. (INGN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 249.44M | 358.11M | 361.94M | 308.49M | 358M | 377.24M | 315.66M | 335.7M | 348.67M | 351.5M |
Revenue Growth % | 22.98% | 43.57% | 1.07% | -14.77% | 16.05% | 5.37% | -16.32% | 6.35% | 3.86% | 3.39% |
Cost of Goods Sold | 128.2M | 179.53M | 190.08M | 170.31M | 181.52M | 223.71M | 188.96M | 180.96M | 182.78M | 180.21M |
COGS % of Revenue | 51.4% | 50.13% | 52.52% | 55.21% | 50.7% | 59.3% | 59.86% | 53.91% | 52.42% | - |
Gross Profit | 121.24M▲ 0% | 178.58M▲ 47.3% | 171.86M▼ 3.8% | 138.18M▼ 19.6% | 176.48M▲ 27.7% | 153.53M▼ 13.0% | 126.7M▼ 17.5% | 154.74M▲ 22.1% | 165.89M▲ 7.2% | 171.29M▲ 0% |
Gross Margin % | 48.6% | 49.87% | 47.48% | 44.79% | 49.3% | 40.7% | 40.14% | 46.09% | 47.58% | 48.73% |
Gross Profit Growth % | 24.59% | 47.3% | -3.76% | -19.6% | 27.72% | -13% | -17.48% | 22.13% | 7.2% | - |
Operating Expenses | 93.65M | 140.69M | 152.07M | 150.21M | 167.24M | 238.78M | 236.09M | 197.26M | 196.09M | 202.26M |
OpEx % of Revenue | 37.54% | 39.29% | 42.02% | 48.69% | 46.72% | 63.3% | 74.79% | 58.76% | 56.24% | - |
Selling, General & Admin | 88.33M | 133.66M | 142.67M | 136.13M | 150.67M | 164.67M | 182.35M | 175.65M | 165.07M | 167.18M |
SG&A % of Revenue | 35.41% | 37.32% | 39.42% | 44.13% | 42.09% | 43.65% | 57.77% | 52.32% | 47.34% | - |
Research & Development | 5.31M | 7.03M | 9.4M | 14.08M | 16.58M | 21.94M | 20.84M | 21.61M | 19.4M | 20.46M |
R&D % of Revenue | 2.13% | 1.96% | 2.6% | 4.56% | 4.63% | 5.82% | 6.6% | 6.44% | 5.56% | - |
Other Operating Expenses | 0 | -696K | 0 | 0 | 0 | 52.16M | 32.89M | 0 | 11.62M | 3M |
Operating Income | 27.59M▲ 0% | 37.89M▲ 37.3% | 19.79M▼ 47.8% | -12.03M▼ 160.8% | 9.24M▲ 176.8% | -85.24M▼ 1022.5% | -109.39M▼ 28.3% | -42.52M▲ 61.1% | -30.21M▲ 29.0% | -30.97M▲ 0% |
Operating Margin % | 11.06% | 10.58% | 5.47% | -3.9% | 2.58% | -22.6% | -34.65% | -12.66% | -8.66% | -8.81% |
Operating Income Growth % | 20.67% | 37.34% | -47.78% | -160.77% | 176.84% | -1022.54% | -28.32% | 61.13% | 28.95% | - |
EBITDA | 39.89M | 49.19M | 33.62M | 6.56M | 30.87M | -61.73M | -91.23M | -21.51M | -9.55M | -10.6M |
EBITDA Margin % | 15.99% | 13.74% | 9.29% | 2.13% | 8.62% | -16.36% | -28.9% | -6.41% | -2.74% | -3.01% |
EBITDA Growth % | 9.53% | 23.3% | -31.64% | -80.5% | 370.84% | -299.98% | -47.8% | 76.42% | 55.62% | 18.3% |
D&A (Non-Cash Add-back) | 12.3M | 11.29M | 13.83M | 18.58M | 21.63M | 23.51M | 18.15M | 21M | 20.66M | 20.37M |
EBIT | 27.59M | 37.89M | 19.79M | -12.03M | 9.24M | -33.08M | -76.49M | -42.52M | -23.38M | -25.53M |
Net Interest Income | 765K | 3.26M | 4.71M | 909K | 129K | 2.84M | 6.57M | 5.19M | 2.15M | 4.14M |
Interest Income | 765K | 3.26M | 4.71M | 909K | 129K | 2.84M | 6.57M | 5.19M | 2.15M | 4.14M |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | 2.07M | 2.56M | 4.48M | 6.75M | -581K | 1.98M | 7.04M | 6.04M | 6.83M | 5.36M |
Pretax Income | 29.66M▲ 0% | 40.45M▲ 36.4% | 24.27M▼ 40.0% | -5.28M▼ 121.8% | 8.66M▲ 264.0% | -83.27M▼ 1061.6% | -102.34M▼ 22.9% | -36.48M▲ 64.4% | -23.38M▲ 35.9% | -25.61M▲ 0% |
Pretax Margin % | 11.89% | 11.3% | 6.71% | -1.71% | 2.42% | -22.07% | -32.42% | -10.87% | -6.71% | -7.28% |
Income Tax | 8.65M | -11.39M | 3.32M | 549K | 14.99M | 504K | 105K | -588K | -632K | -709K |
Effective Tax Rate % | 29.18% | -28.15% | 13.69% | -10.4% | 173.14% | -0.61% | -0.1% | 1.61% | 2.7% | 2.77% |
Net Income | 21M▲ 0% | 51.84M▲ 146.9% | 20.95M▼ 59.6% | -5.83M▼ 127.8% | -6.33M▼ 8.6% | -83.77M▼ 1222.8% | -102.45M▼ 22.3% | -35.89M▲ 65.0% | -22.75M▲ 36.6% | -24.9M▲ 0% |
Net Margin % | 8.42% | 14.48% | 5.79% | -1.89% | -1.77% | -22.21% | -32.46% | -10.69% | -6.52% | -7.08% |
Net Income Growth % | 2.35% | 146.86% | -59.59% | -127.82% | -8.65% | -1222.79% | -22.3% | 64.97% | 36.62% | 9.41% |
Net Income (Continuing) | 21M | 51.84M | 20.95M | -5.83M | -6.33M | -83.77M | -102.45M | -35.89M | -22.75M | -24.9M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.96▲ 0% | 2.30▲ 139.6% | 0.94▼ 59.1% | -0.27▼ 128.7% | -0.28▼ 3.7% | -3.67▼ 1210.7% | -4.42▼ 20.4% | -1.52▲ 65.6% | -0.85▲ 44.1% | -0.91▲ 0% |
EPS Growth % | -1.03% | 139.58% | -59.13% | -128.72% | -3.7% | -1210.71% | -20.44% | 65.61% | 44.08% | 20.87% |
EPS (Basic) | 1.02 | 2.30 | 0.96 | -0.27 | -0.28 | -3.67 | -4.42 | -1.52 | -0.85 | - |
Diluted Shares Outstanding | 21.9M | 22.51M | 22.24M | 21.98M | 22.49M | 22.85M | 23.18M | 23.65M | 27.18M | 27.32M |
Basic Shares Outstanding | 20.68M | 22.51M | 21.82M | 21.98M | 22.49M | 22.85M | 23.18M | 23.65M | 27.18M | 27.32M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
INGN Balance Sheet
Inogen, Inc. (INGN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 228.49M | 314.58M | 292.22M | 305.7M | 329.19M | 304.64M | 207.07M | 185.45M | 198.3M | 190.66M |
Cash & Short-Term Investments | 173.94M | 240.35M | 209.09M | 231.22M | 245.51M | 187.01M | 128.47M | 113.8M | 119.58M | 111.47M |
Cash Only | 142.95M | 196.63M | 198.04M | 211.96M | 235.52M | 187.01M | 125.49M | 113.8M | 103.73M | 94.41M |
Short-Term Investments | 30.99M | 43.72M | 11.06M | 19.26M | 9.99M | 0 | 2.98M | 0 | 15.85M | 17.06M |
Accounts Receivable | 32.76M | 39.7M | 37.3M | 31.77M | 25.8M | 64.35M | 42.91M | 30.1M | 38.86M | 41.87M |
Days Sales Outstanding | 47.93 | 40.46 | 37.62 | 37.58 | 26.3 | 62.26 | 49.62 | 32.73 | 40.68 | 41.46 |
Inventory | 18.84M | 27.07M | 35.66M | 24.82M | 31.87M | 34.09M | 21.84M | 24.81M | 25.97M | 24.99M |
Days Inventory Outstanding | 53.64 | 55.04 | 68.48 | 53.18 | 64.09 | 55.63 | 42.19 | 50.05 | 51.86 | 50.81 |
Other Current Assets | 1.67M | 0 | 0 | 0 | 0 | 19.19M | 13.85M | 16.74M | 13.89M | 12.33M |
Total Non-Current Assets | 46.58M | 61.31M | 155.12M | 156.16M | 160.33M | 100.4M | 119.13M | 110.73M | 100.33M | 95.26M |
Property, Plant & Equipment | 20.1M | 22.34M | 25.29M | 37.06M | 63.84M | 64.92M | 70.65M | 62.7M | 52.86M | 49.41M |
Fixed Asset Turnover | 12.41x | 16.03x | 14.31x | 8.32x | 5.61x | 5.81x | 4.47x | 5.35x | 6.60x | 6.54x |
Goodwill | 2.36M | 2.26M | 32.95M | 33.16M | 32.98M | 32.85M | 10.06M | 9.46M | 10.7M | 10.48M |
Intangible Assets | 4.72M | 3.75M | 77.53M | 68.8M | 60.15M | 177K | 34.59M | 30.49M | 30.76M | 28.91M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 765K | 2.83M | 4.89M | 2.67M | 3.36M | 2.44M | 3.83M | 8.08M | 6M | 6.45M |
Total Assets | 275.07M▲ 0% | 375.9M▲ 36.7% | 447.34M▲ 19.0% | 461.85M▲ 3.2% | 489.51M▲ 6.0% | 405.04M▼ 17.3% | 326.19M▼ 19.5% | 296.19M▼ 9.2% | 298.63M▲ 0.8% | 285.93M▲ 0% |
Asset Turnover | 0.91x | 0.95x | 0.81x | 0.67x | 0.73x | 0.93x | 0.97x | 1.13x | 1.17x | 1.17x |
Asset Growth % | 28.51% | 36.65% | 19.01% | 3.24% | 5.99% | -17.26% | -19.47% | -9.2% | 0.82% | -5.18% |
Total Current Liabilities | 33.89M | 46.59M | 50.18M | 56.71M | 61.51M | 65.35M | 72.5M | 76.69M | 63.53M | 61.45M |
Accounts Payable | 9.54M | 13.72M | 16.4M | 12.52M | 10.26M | 18.24M | 13.45M | 16.62M | 29.44M | 31.3M |
Days Payables Outstanding | 27.16 | 27.89 | 31.49 | 26.83 | 20.63 | 29.76 | 25.99 | 33.51 | 58.79 | 59.16 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.16M | 3.49M |
Deferred Revenue (Current) | 3.53M | 4.45M | 5.48M | 6.99M | 8.57M | 8.88M | 7.98M | 6.65M | 5.5M | 22.82M |
Other Current Liabilities | 6.34M | 7.02M | 8.13M | 17.91M | 6.48M | 7.79M | 19.63M | 22.74M | 25.25M | 11.38M |
Current Ratio | 6.74x | 6.75x | 5.82x | 5.39x | 5.35x | 4.66x | 2.86x | 2.42x | 3.12x | 3.10x |
Quick Ratio | 6.19x | 6.17x | 5.11x | 4.95x | 4.83x | 4.14x | 2.55x | 2.09x | 2.71x | 2.70x |
Cash Conversion Cycle | 74.41 | 67.6 | 74.61 | 63.93 | 69.76 | 88.13 | 65.82 | 49.26 | 33.75 | 33.11 |
Total Non-Current Liabilities | 14.14M | 18.89M | 52.54M | 55.52M | 57.77M | 42.29M | 48.89M | 45.64M | 42.86M | 41.57M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 4.7M | 8.08M | 23.28M | 19.76M | 18.27M | 16.59M | 14.31M | 58.81M |
Deferred Tax Liabilities | 348K | 232K | 87K | 25K | 0 | 0 | 8.54M | 6.95M | 6.75M | 29.16M |
Other Non-Current Liabilities | 4.39M | 6.81M | 34.21M | 35.59M | 22.63M | 12.12M | 13.85M | 16.35M | 18.19M | 18.39M |
Total Liabilities | 48.03M | 65.47M | 102.72M | 112.23M | 119.29M | 107.64M | 121.38M | 122.33M | 106.39M | 103.02M |
Total Debt | 0 | 0 | 6.72M | 10.01M | 26.67M | 23.28M | 21.92M | 19.41M | 17.48M | 16.93M |
Net Debt | -142.95M | -196.63M | -191.32M | -201.95M | -208.85M | -163.74M | -103.57M | -94.39M | -86.25M | -77.47M |
Debt / Equity | - | - | 0.02x | 0.03x | 0.07x | 0.08x | 0.11x | 0.11x | 0.09x | 0.09x |
Debt / EBITDA | - | - | 0.20x | 1.53x | 0.86x | - | - | - | - | -1.60x |
Net Debt / EBITDA | -3.58x | -4.00x | -5.69x | -30.80x | -6.77x | - | - | - | - | 7.31x |
Interest Coverage | - | - | - | - | - | - | - | - | - | - |
Total Equity | 227.04M▲ 0% | 310.42M▲ 36.7% | 344.62M▲ 11.0% | 349.62M▲ 1.5% | 370.23M▲ 5.9% | 297.41M▼ 19.7% | 204.81M▼ 31.1% | 173.86M▼ 15.1% | 192.23M▲ 10.6% | 182.91M▲ 0% |
Equity Growth % | 24.69% | 36.73% | 11.02% | 1.45% | 5.89% | -19.67% | -31.13% | -15.11% | 10.57% | 15.66% |
Book Value per Share | 10.37 | 13.79 | 15.49 | 15.91 | 16.46 | 13.01 | 8.84 | 7.35 | 7.07 | 6.69 |
Total Shareholders' Equity | 227.04M | 310.42M | 344.62M | 349.62M | 370.23M | 297.41M | 204.81M | 173.86M | 192.23M | 182.91M |
Common Stock | 21K | 22K | 22K | 22K | 23K | 23K | 23K | 24K | 27K | 27K |
Retained Earnings | 8.64M | 60.48M | 81.43M | 75.61M | 69.27M | -14.5M | -116.95M | -152.84M | -175.58M | -183.91M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 272K | 724K | -87K | 475K | 1.47M | -243K | 1.23M | -1.5M | 4.24M | 3.42M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
INGN Cash Flow Statement
Inogen, Inc. (INGN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 60.49M | 59.98M | 40.59M | 37.01M | 23.63M | -37.53M | -3.23M | 5.91M | -11.22M | -1.11M |
Operating CF Margin % | 24.25% | 16.75% | 11.22% | 12% | 6.6% | -9.95% | -1.02% | 1.76% | -3.22% | - |
Operating CF Growth % | 94.93% | -0.85% | -32.32% | -8.82% | -36.15% | -258.81% | 91.38% | 282.87% | -289.65% | 24.96% |
Net Income | 21M | 51.84M | 20.95M | -5.83M | -6.33M | -83.77M | -102.45M | -35.89M | -22.75M | -24.9M |
Depreciation & Amortization | 12.3M | 11.29M | 13.83M | 18.58M | 21.63M | 23.51M | 18.15M | 21M | 20.66M | 20.37M |
Stock-Based Compensation | 9.64M | 12.79M | 9.13M | 8.2M | 10.94M | 12.28M | 7.43M | 7.4M | 8.01M | 5.87M |
Deferred Taxes | 7.95M | -11.6M | 2.87M | -82K | 14.44M | 0 | -251K | -1.15M | -1.1M | -1.6M |
Other Non-Cash Items | 20.24M | 21.29M | 21.69M | 16.17M | 3.02M | 55.16M | 59.62M | 18.94M | 10.87M | 13.02M |
Working Capital Changes | -10.64M | -25.65M | -27.89M | -31K | -20.07M | -44.72M | 14.27M | -4.39M | -26.91M | -13.88M |
Change in Receivables | -18.26M | -25.96M | -17.03M | -7.25M | -5.42M | -51.62M | 11.13M | -5.07M | -14.62M | -11.95M |
Change in Inventory | -5.89M | -9.97M | -10.34M | 7.59M | -10.78M | -5.6M | 7.88M | -3.54M | -3.21M | -4.11M |
Change in Payables | 7.44M | 6.36M | 3.2M | -5.83M | -6.48M | 6.76M | -9.18M | -3.41M | 5.6M | -2.63M |
Cash from Investing | -24.43M | -24.96M | -44.06M | -25.64M | -14.64M | -10.88M | -59.31M | -13.97M | -26.21M | -26.15M |
Capital Expenditures | -10.23M | -12.97M | -6.26M | -17.6M | -24.07M | -21.22M | -27.01M | 0 | -10.38M | -9.13M |
CapEx % of Revenue | 4.1% | 3.62% | 1.73% | 5.7% | 6.72% | 5.63% | 8.56% | 5.09% | 2.98% | 2.6% |
Acquisitions | -4.49M | 350K | -70.4M | 163K | 153K | 331K | -29.43M | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 183K | 365K | -60K | 0 | 0 | 0 | 0 | -16.82M | 0 | 0 |
Cash from Financing | 14M | 18.3M | 4.93M | 2.07M | 15M | 380K | 960K | 265K | 24.18M | -1.89M |
Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 0 | 0 | 0 | 2.42M | 15.65M | 1.74M | 1.48M | 811K | 28.18M | -1.02M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | -1.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.87M |
Other Financing | 14M | 18.3M | 4.93M | -350K | -647K | -1.35M | -518K | -546K | -4M | -873K |
Net Change in Cash | 50.1M▲ 0% | 53.68M▲ 7.1% | 1.4M▼ 97.4% | 13.93M▲ 892.5% | 23.56M▲ 69.2% | -48.51M▼ 305.9% | -61.52M▼ 26.8% | -8.08M▲ 86.9% | -12.4M▼ 53.5% | -28.13M▲ 0% |
Free Cash Flow | 50.27M▲ 0% | 47M▼ 6.5% | 34.08M▼ 27.5% | 19.67M▼ 42.3% | -302K▼ 101.5% | -58.75M▼ 19355.0% | -29.75M▲ 49.4% | -11.18M▲ 62.4% | -21.6M▼ 93.2% | -10.24M▲ 0% |
FCF Margin % | 20.15% | 13.13% | 9.42% | 6.38% | -0.08% | -15.57% | -9.43% | -3.33% | -6.19% | -2.91% |
FCF Growth % | 118.38% | -6.49% | -27.5% | -42.28% | -101.54% | -19354.97% | 49.36% | 62.42% | -93.21% | 51.55% |
FCF per Share | 2.30 | 2.09 | 1.53 | 0.89 | -0.01 | -2.57 | -1.28 | -0.47 | -0.79 | -0.37 |
FCF Conversion (FCF/Net Income) | 2.88x | 1.16x | 1.94x | -6.35x | -3.73x | 0.45x | 0.03x | -0.16x | 0.49x | 0.41x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 1.27M | 1.65M | 239K | 0 | 0 | 0 | 0 | 375K | 0 | 84K |
INGN Key Ratios
Inogen, Inc. (INGN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 10.27% | 19.29% | 6.4% | -1.68% | -1.76% | -25.1% | -40.8% | -18.95% | -12.43% | -12.9% |
Return on Invested Capital (ROIC) | 23.88% | 28.72% | 11.11% | -5.99% | 4.48% | -43.34% | -69.85% | -35.29% | -24.43% | -21.41% |
Gross Margin | 48.6% | 49.87% | 47.48% | 44.79% | 49.3% | 40.7% | 40.14% | 46.09% | 47.58% | 48.73% |
Net Margin | 8.42% | 14.48% | 5.79% | -1.89% | -1.77% | -22.21% | -32.46% | -10.69% | -6.52% | -7.08% |
Debt / Equity | - | - | 0.02x | 0.03x | 0.07x | 0.08x | 0.11x | 0.11x | 0.09x | 0.09x |
FCF Conversion | 2.88x | 1.16x | 1.94x | -6.35x | -3.73x | 0.45x | 0.03x | -0.16x | 0.49x | 0.41x |
Revenue Growth | 22.98% | 43.57% | 1.07% | -14.77% | 16.05% | 5.37% | -16.32% | 6.35% | 3.86% | 3.39% |
Related:INGN Dividend History·INGN Revenue History·INGN Price History·INGN P/E History·INGN Financial Ratios·INGN Institutional Holders
INGN SEC Filings & Documents
Inogen, Inc. (INGN) SEC filings — annual & quarterly reports (10-K, 10-Q)
INGN Frequently Asked Questions
Inogen, Inc. (INGN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Inogen, Inc. (INGN) reported $351.5M in revenue for fiscal year 2025. This represents a 1047% increase from $30.6M in 2011.
Inogen, Inc. (INGN) grew revenue by 3.9% over the past year. Growth has been modest.
Inogen, Inc. (INGN) reported a net loss of $24.9M for fiscal year 2025.
Dividend & Returns
Inogen, Inc. (INGN) has a return on equity (ROE) of -12.4%. Negative ROE indicates the company is unprofitable.
Inogen, Inc. (INGN) had negative free cash flow of $10.2M in fiscal year 2025, likely due to heavy capital investments.